A Multi-Center, Randomized, Controlled, Double-Blind Study of the Effects of an Antioxidant-Enriched Multivitamin Supplement on Inflammation and Oxidative Stress in Cystic Fibrosis Patients
The purpose of this study in Cystic Fibrosis will be to further evaluate the effects of a modified formulation of AquADEKs® (AquADEKs-2) on markers of inflammation, antioxidant levels, and oxidative stress.
You may be eligible if you are over 12 years of age, have cystic fibrosis, and have pancreatic insufficiency.
Cystic Fibrosis Foundation Therapeutics
Cori Daines, MD
Osmara Y. Molina de Rodriguez, MS
Cell: (520) 891-6767 or Office: (520) 626-3910